As of the latest SEC filings, Allogene Therapeutics, Inc. (ALLO) is held by 145 institutional funds. The largest fund shareholder is VANGUARD CAPITAL OPPORTUNITY FUND (VHCAX), holding an estimated $13,089,550.80 in market value, representing 0.05% of its portfolio.
Funds holding Allogene Therapeutics, Inc. (ALLO)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- ALLO
- CIK:
- 0001737287
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VHCAX
VANGUARD CAPITAL OPPORTUNITY FUND
|
MF | Vanguard | 0.05% | $13,089,550.80 | 5,364,570 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.17% | $12,718,758.64 | 5,212,606 | Mar 31, 2026 | May 28, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $11,905,226.04 | 4,879,191 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.01% | $9,357,280.44 | 3,834,951 | Mar 31, 2026 | May 28, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.09% | $9,347,635.12 | 3,830,998 | Mar 31, 2026 | May 28, 2026 |
|
POAGX
PRIMECAP Odyssey Aggressive Growth Fund
|
MF | Independent / Boutique | 0.11% | $7,189,325.10 | 3,375,270 | Apr 30, 2026 | Jun 29, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $4,591,743.28 | 1,881,862 | Mar 31, 2026 | May 28, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.07% | $3,895,099.70 | 1,401,115 | Feb 28, 2026 | Apr 24, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 0.64% | $3,567,814.36 | 1,462,219 | Mar 31, 2026 | May 29, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.05% | $3,360,636.36 | 1,208,862 | Feb 27, 2026 | Apr 24, 2026 |
|
TCSEX
Nuveen Quant Small Cap Equity Fund
|
MF | TIAA / Nuveen | 0.09% | $3,333,876.00 | 1,565,200 | Apr 30, 2026 | Jun 24, 2026 |
|
IWN
iShares Russell 2000 Value ETF
|
ETF | BlackRock / iShares | 0.03% | $3,315,206.04 | 1,358,691 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.01% | $3,290,662.56 | 1,544,912 | Apr 30, 2026 | Jun 26, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.03% | $2,795,195.68 | 1,145,572 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.01% | $2,413,223.48 | 868,066 | Feb 28, 2026 | Apr 24, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.01% | $2,190,837.38 | 788,071 | Feb 28, 2026 | Apr 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.01% | $2,124,078.46 | 764,057 | Feb 28, 2026 | Apr 28, 2026 |
|
DFAS
Dimensional U.S. Small Cap ETF
|
ETF | Dimensional Fund Advisors | 0.01% | $1,866,734.13 | 876,401 | Apr 30, 2026 | Jun 29, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.01% | $1,257,469.06 | 452,327 | Feb 28, 2026 | Apr 28, 2026 |
|
PRFZ
Invesco RAFI US 1500 Small-Mid ETF
|
ETF | Invesco | 0.04% | $1,179,131.79 | 553,583 | Apr 30, 2026 | Jun 26, 2026 |
|
GMDZX
MEDIUM-DURATION BOND FUND
|
MF | Independent / Boutique | 0.03% | $1,009,850.05 | 1,000,000 | Mar 31, 2026 | May 28, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $905,393.18 | 325,681 | Feb 28, 2026 | Apr 24, 2026 |
|
BMEZ
BlackRock Health Sciences Term Trust
|
CEF | BlackRock / iShares | 0.08% | $851,259.88 | 348,877 | Mar 31, 2026 | May 28, 2026 |
|
ITOT
iShares Core S&P Total U.S. Stock Market ETF
|
ETF | BlackRock / iShares | 0.00% | $843,078.56 | 345,524 | Mar 31, 2026 | May 28, 2026 |
|
JSVZX
JPMorgan Small Cap Value Fund
|
MF | JPMorgan | 0.07% | $764,156.76 | 313,179 | Mar 31, 2026 | May 29, 2026 |
Advertisement (320x50)